SANSONE, S.; AMIR, Y.; LEBWOHL, M. Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 3, p. 256–259, 2020. DOI: 10.25251/skin.4.3.7. Disponível em: https://jofskin.org/index.php/skin/article/view/651. Acesso em: 11 apr. 2021.